hcc

Interferon treatment for chronic hepatitis C reduces the incidence of hepatocellular carcinoma ( HCC ) in sustained responders.

干扰素治疗慢性丙型肝炎发生持续应答的患者肝细胞癌 ( HCC ) 的发生率显著降低.

International Digest: Currently most of the therapeutic strategies for HCC are not totally satisfactory.

国际肝病: 目前大多数的HCC治疗策略不能令人完全满意.

Incorporation of these molecular markers could help to improve organ allocation for HCV-HCC patients.

合并这些分子标志物有助于改善HCV -HCC 患者的器官配置.

Objective To study the mechanism of spontaneous rupture of hepatocellular carcinoma ( HCC ) .

目的探讨 肝癌 自发性破裂的机理.

Objective To investigate the effect of antiandrogen on hepatocellular carcinoma ( HCC ).

目的探讨抗雄激素治疗肝癌 ( HCC ) 的效果.

Samples from 12 hepatitis B virus-associated HCC patients were analyzed.

我们分析了来源于12名乙肝病毒相关性HCC患者的样品.

Background. Liver transplantation ( LT ) represents a curative treatment for small hepatocellular carcinoma ( HCC ).

对于小肝癌 ( HCC ) 的患者而言,肝移植是一种根治疗法.

Objective To analyze the risk factors for metastasis and recurrence of hepatocellular carcinoma ( HCC ) postoperatively.

目的:分析研究肝细胞癌 ( HCC ) 术后复发转移的相关危险因素.

TACE via the IPA is a safe and efficient for HCC.

经膈下动脉介入化疗栓塞原发性肝癌是安全有效的介入治疗方法.

Introduction of some new techniques exploited in our country including DCC, MGG , MIO, ARGG and HCC are also given.

介绍了我国新近开发的DCC 、 MGG 、 MIO 、 ARGG、HCC等 几种典型的先进工艺.

Could you give us a brief introduction to some of the novel therapeutic targets for HCC?

您能给我们简要介绍一些新的HCC靶 向治疗策略 吗 ?

Materials and Methods: Sixty-six patients with HCC underwent HAG and subsequent MRI in 10 days.

材料与方法：研究对象：于MRI检查后10日内行肝血管造影检查的HCC患者66例。

How about the future outlook of molecular target therapy treating HCC?

分子靶向治疗肝细胞性肝癌的前景如何?

Conclusions : Plasma MAD 2 might be a significant parameter for diagnosis and prognosis of patients with HCC.

结论血浆MAD2检测有望成为HCC诊断及预后判断的又一重要参数.

Conclusion The over expression of cyclinD 1 may participate in the carcinogenesis and progression of HCC.

结论CyclinD1基因的过度表达可能参与HCC的发生、发展.